BCM-0002 | 24452 | Invasive ductal carcinoma | Not Reported | Not Reported | Not Reported | Negative | Negative | Negative | Wild type | Wild type | Not Reported | | Distant Metastasis | 43.62 | Black or African American | No | Anastrozole,Capecitabine,Carboplatin,Docetaxel,Doxorubicin,Gemcitabine,Letrozole,Paclitaxel,Tamoxifen |
BCM-0046 | 2219 | Infiltrating duct carcinoma, NOS | Negative | Negative | Negative | Negative | Negative | Negative | Wild type | Wild type | | G3 (Poorly Differentiated) | Primary | 53.47 | Hispanic or Latino | No | Cyclophosphamide,Docetaxel,Epirubicin |
BCM-0104 | 24561 | Infiltrating duct carcinoma, NOS | Negative | Negative | Negative | Negative | Negative | Negative | Not Reported | Not Reported | Not Reported | G3 (Poorly Differentiated) | Primary | 58.11 | White | No | Paclitaxel |
BCM-0113 | 4661 | Infiltrating duct carcinoma, NOS | Negative | Negative | Negative | Negative | Negative | Negative | Wild type | Wild type | Not Reported | G3 (Poorly Differentiated) | Distant Metastasis | 63.38 | Hispanic or Latino | No | Capecitabine,Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin,Ixabepilone,Paclitaxel |
BCM-0132 | 28918 | Infiltrating duct carcinoma, NOS | Negative | Negative | Negative | Negative | Negative | Negative | Wild type | Wild type | 3b | G3 (Poorly Differentiated) | Primary | 58.89 | Black or African American | Yes | Capecitabine,Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin,Paclitaxel |
BCM-15003 | 14310 | Adenoid cystic carcinoma | Negative | Negative | Negative | Negative | Negative | Negative | Wild type | Wild type | | | Primary | 66.37 | Hispanic or Latino | Yes | Cyclophosphamide,Docetaxel |
BCM-15006 | 13611 | Adenocarcinoma, metastatic, NOS | Not Reported | Not Reported | Not Reported | Negative | Negative | Negative | Wild type | Wild type | Not Reported | G3 (Poorly Differentiated) | Primary | 33.91 | White | No | Capecitabine,Carboplatin,Cisplatin,Cyclophosphamide,Doxorubicin,Eribulin,Paclitaxel |
BCM-15029 | 32158 | Infiltrating duct carcinoma, NOS | Negative | Negative | Negative | Negative | Negative | Negative | Wild type | Wild type | | G3 (Poorly Differentiated) | Second Primary | 46.87 | White,Hispanic or Latino | No | Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin |
BCM-15030 | 32323 | Invasive ductal carcinoma | Not Reported | Not Reported | Not Reported | Positive | Positive | Negative | Wild type | Wild type | Not Reported | | Distant Metastasis | 34.25 | White | No | Anastrozole,Capecitabine,Cyclophosphamide,Doxorubicin,Everolimus,Exemestane,Experimental Drugs,Fluorouracil,Fulvestrant,Goserelin,High-dose estrogen,Letrozole,Megestrol acetate,Other,Paclitaxel,Palbociclib,Tamoxifen |
BCM-15034 | 33355 | Infiltrating duct carcinoma, NOS | Positive | Negative | Negative | Positive | Positive | Unknown | Wild type | Wild type | | G3 (Poorly Differentiated) | Distant Metastasis | 62.88 | White | No | Anastrozole,Capecitabine,Docetaxel,Eribulin,Everolimus,Exemestane,Letrozole,Paclitaxel,Palbociclib,Pertuzumab,Trastuzumab |
BCM-15046 | 13611 | Adenocarcinoma, metastatic, NOS | Not Reported | Not Reported | Not Reported | Negative | Negative | Negative | Wild type | Wild type | Not Reported | G3 (Poorly Differentiated) | Distant Metastasis | 33.91 | White | No | Capecitabine,Carboplatin,Cisplatin,Cyclophosphamide,Doxorubicin,Eribulin,Paclitaxel |
BCM-15051 | 35624 | Carcinoma, NOS | Negative | Positive | Negative | Negative | Negative | Negative | Not Reported | | 3b | | Primary | 59.42 | White | No | Carboplatin,Cyclophosphamide,Doxorubicin,Paclitaxel |
BCM-15057 | 36302 | Infiltrating duct carcinoma, NOS | Positive | Positive | Negative | Positive | Positive | Negative | Not Reported | Not Reported | Not Reported | G3 (Poorly Differentiated) | Primary | 80.08 | Hispanic or Latino | No | Anastrazole,Exemestane,Paclitaxel |
BCM-15100 | 24590 | Infiltrating duct carcinoma, NOS | Positive | Positive | Negative | Positive | Positive | Negative | Not Reported | Not Reported | | | Distant Metastasis | 38.00 | White | | Capecitabine,Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin,Eribulin,Fulvestrant,Letrozole,Leuprolide,Other,Paclitaxel,Palbociclib,Tamoxifen |
BCM-15115 | 39639 | Infiltrating duct carcinoma, NOS | Negative | Negative | Negative | Not Reported | Not Reported | Not Reported | Not Reported | Not Reported | 2a | G3 (Poorly Differentiated) | Primary | 63.76 | Hispanic or Latino | No | Anastrazole,Paclitaxel |